Report
Dr. Michael Green

Rainbow Rare Earths - Initiation of Coverage

Production to be rapidly ramped up at one of the highest grade REE producers globally and one of the few outside of China

Rainbow Rare Earths Ltd listed on the LSE in 2017 at 10p per share and has a 90% stake in the Gakara Rare Earths Project in Burundi. This boasts some of the highest grades of Rare Earth Elements (REEs) on the planet. A recent maiden JORC compliant resource statement outlined 1.2Mt on just a small part of this vast 39km² licence area, confirming the true scale of the deposit for the very first time. Investor excitement sent the shares to 23p, but recently the stock has been oversold due to production delays and financing concerns.

  • REE production being ramped up targeting break-even by H2 2019

    Mining began in September 2017 and is on course to achieve break-even in H2 2019 from two mining areas. This is dependent on the opening of another two areas which are planned to allow production to increase. Demand is very strong from end customers secured by partner Thyssenkrupp under a 10-year offtake deal for up to 5,000 tpa, plus first right of refusal on the next 5,000 tpa.

  • Scope to capture far higher margins with downstream processing

    JV partner TechMet is to fund a DFS to determine the economic feasibility of processing the concentrate into separate REEs, which could reduce the discount to metal content price considerably from the current 70%.

  • Escalating US-China trade war looks likely to spill over into REEs

    REEs are strategic commodities with deposits outside of China becoming strategically important. Rainbow has just started to attract attention for being just one of two quoted commercial REE producers outside of China.

  • Highly conservative NPV suggests upside of 70%

    Our conservative valuation shows the potential. We initiate coverage of Rainbow with a target price of 10.53p and Conviction buy stance.

Underlying
Rainbow Rare Earths

Rainbow Rare Earths is engaged in the exploration and mining of rare earth minerals at its Gakara Project in Burundi.

Provider
Align Research
Align Research

Align Research is a commissioned research company founded in November 2015 in order to provide the under-served smaller company space with high quality analysis. We have an initial focus on the natural resources sector, in which we see significant opportunities given the current once in a generation bear market, however all undervalued small caps (sub £100m) are considered by our team. Align was founded by industry professionals with decades of experience in the stock markets, headed up by highly qualified individuals from both fund management and analytical backgrounds.

Analysts
Dr. Michael Green

Other Reports on these Companies
Other Reports from Align Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch